Achieve Life Sciences
ACHV
13 hedge funds and large institutions have $3.79M invested in Achieve Life Sciences in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
24% more capital invested
Capital invested by funds: $3.04M → $3.79M (+$745K)
0% more funds holding
Funds holding: 13 → 13 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
7.83% less ownership
Funds ownership: 20.44% → 12.61% (-7.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$928K |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$306K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$229K |
| 4 |
Morgan Stanley
New York
|
+$146K |
| 5 |
HR
Hayden Royal
Charlotte,
North Carolina
|
+$123K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$726K |
| 2 |
Renaissance Technologies
New York
|
-$198K |
| 3 |
SC
Searle & Co
Greenwich,
Connecticut
|
-$45K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$23.6K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$16K |
ACHV Hedge Fund Activity: Q3 2020 in Review
13 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2020, worth a combined $3.79M — up 24% from $3.04M a quarter earlier.
Fund positioning in ACHV was balanced in Q3 2020: 6 funds opened new positions, 6 closed out, 3 added to existing stakes and 3 trimmed.
The largest buyer was Ikarian Capital, adding an estimated $928K. The largest seller was CVI Holdings, exiting entirely with an estimated $726K sold.
- 13 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $3.79M of Achieve Life Sciences stock for Q3 2020, up 24% quarter-over-quarter.
- 6 funds opened new Achieve Life Sciences positions in Q3 2020 and 6 closed out, a net change of 0 holders.
- The largest Achieve Life Sciences buyer in Q3 2020 was Ikarian Capital, an estimated $928K added.
- The largest Achieve Life Sciences seller in Q3 2020 was CVI Holdings, an estimated $726K sold.
Based on aggregated 13F filings for Q3 2020.